CASI Pharmaceuticals
CASI
#11079
Rank
HK$33.43 M
Marketcap
HK$1.63
Share price
0.00%
Change (1 day)
-87.46%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): -HK$21.61

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$21.72. In 2024 the company made an earnings per share (EPS) of -HK$20.08 a decrease over its 2023 EPS that were of -HK$15.84.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$21.617.62%
2024-HK$20.0826.73%
2023-HK$15.84-32.89%
2022-HK$23.6111.9%
2021-HK$21.10-38.44%
2020-HK$34.27-8.96%
2019-HK$37.6550%
2018-HK$25.1077.78%
2017-HK$14.125.88%
2016-HK$13.33-22.73%
2015-HK$17.25-76.09%
2014-HK$72.15318.18%
2013-HK$17.25-71.79%
2012-HK$61.1765.96%
2011-HK$36.86-50%
2010-HK$73.72-18.97%
2009-HK$90.98-63.64%
2008-HK$250.193.57%
2007-HK$241.56-60.56%
2006-HK$612.5297.22%
2005-HK$310.58-2.7%
2004-HK$319.20-45.59%
2003-HK$586.64-61.8%
2002-HK$1,536-25.52%
2001-HK$2,062-21.38%
2000-HK$2,62313.86%
1999-HK$2,303149.53%
1998-HK$923.1098.15%
1997-HK$465.8610.2%
1996-HK$422.73